A detailed history of Linker Capital Management Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Linker Capital Management Inc. holds 8,101 shares of BMY stock, worth $475,852. This represents 0.68% of its overall portfolio holdings.

Number of Shares
8,101
Previous 8,101 -0.0%
Holding current value
$475,852
Previous $561,000 7.66%
% of portfolio
0.68%
Previous 0.62%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 02, 2022

SELL
$0.13 - $76.84 $20 - $12,371
-161 Reduced 1.95%
8,101 $576,000
Q2 2022

Aug 01, 2022

SELL
$72.62 - $79.98 $726 - $799
-10 Reduced 0.12%
8,262 $636,000
Q4 2021

Jan 21, 2022

BUY
$53.63 - $62.52 $443,627 - $517,165
8,272 New
8,272 $516,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Linker Capital Management Inc. Portfolio

Follow Linker Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Linker Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Linker Capital Management Inc. with notifications on news.